Shorter Duration of Post-Operative Antibiotics for Cecal Ligation and Puncture Does Not Increase Inflammation or Mortality.
Antimicrobial therapy for sepsis has beneficial effects, but prolonged use fosters emergence of resistant microorganisms, increases cost, and secondary infections. We tested whether 3 days versus 5 days of antibiotics in the murine model of cecal ligation and puncture (CLP) negatively influences outcomes. Following CLP mice were randomized to receive the antibiotic imipenem-cilastatin (25mg/kg) in dextrose 5% in Lactated Ringer's solution every 12 hours for either three or five days. Serial monitoring over 28 days included body weight, temperature, pulse oximetry, and facial vein sampling for hematological analysis and glucose. A separate group of mice were euthanized on post-CLP day 5 to measure cytokines and peritoneal bacterial counts. The first study examined no antimicrobial therapy and demonstrated that antibiotics significantly improved survival compared to fluids only (p = 0.004). We next tested imipenem-cilastatin therapy for 3 days versus 5 days. Body weight, temperature, glucose, and pulse oximetry measurements remained generally consistent between both groups as did the hematological profile. Pro-inflammatory plasma cytokines were comparable between both groups for IL-6, IL-1β, MIP-2 and anti-inflammatory cytokines IL-10, and TNF SRI. At 5 days post-CLP, i.e. 2 days after the termination of antibiotics in the 3 day group, there were no differences in the number of peritoneal bacteria. Importantly, shortening the course of antibiotics by 40% (from 5 days to 3 days) did not decrease survival. Our results indicate that reducing the duration of broad-spectrum antibiotics in murine sepsis did not increase inflammation or mortality.
Department of Surgery, Boston University Medical Center, 88 East Newton Street, C 515, Boston, MA, 02118, United States of America.
Kendra N
KN
Iskander
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Room 441, Boston, MA, 02118, United States of America.
Max
M
Vaickus
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Room 441, Boston, MA, 02118, United States of America.
Elizabeth R
ER
Duffy
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Room 441, Boston, MA, 02118, United States of America.
Daniel G
http://orcid.org/0000-0002-2615-3713
DG
Remick
Crit Care Med. 2013 Oct;41(10 ):2336-43
23921272
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1167-72
25092317
Mediators Inflamm. 2015;2015:826319
26693207
Crit Care Med. 2010 Apr;38(4):1045-53
20048677
Nutrients. 2016 Mar 15;8(3):165
26999192
Crit Care Med. 2016 Aug;44(8):e711-20
27031380
J Immunol. 2007 Jul 1;179(1):623-30
17579084
Shock. 1995 Aug;4(2):89-95
7496903
PLoS One. 2016 Apr 14;11(4):e0153607
27078880
Ann Surg. 1982 Jan;195(1):19-24
7055379
Shock. 1998 Aug;10(2):110-7
9721977
Crit Care Med. 2011 Jul;39(7):1792-9
21358400
Crit Care Med. 2013 Jan;41(1):159-70
23222255
Shock. 2004 Jan;21(1):17-25
14676679
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12
23401516
Shock. 2014 Feb;41(2):97-103
24300829
J Surg Res. 1980 Aug;29(2):189-201
6997619
Nature. 2014 Jan 30;505(7485):612-3
24482835
Shock. 2010 Oct;34(4):369-76
20610941
Med J Aust. 2015 Jun 15;202(11):571
26068682
N Engl J Med. 2015 May 21;372(21):1996-2005
25992746
Cochrane Database Syst Rev. 2015 Aug 24;(8):CD007577
26301604
Shock. 2004 Feb;21(2):121-5
14752284
PLoS One. 2015 Jul 21;10(7):e0133227
26197455
Shock. 2002 Jun;17(6):463-7
12069181
Chest. 2011 Nov;140(5):1223-31
21852297
PLoS One. 2016 Mar 28;11(3):e0149069
27018973
Physiol Rev. 2013 Jul;93(3):1247-88
23899564
Chest. 2000 Jul;118(1):146-55
10893372
J Immunol Methods. 2001 Sep 1;255(1-2):149-57
11470295
Lancet Infect Dis. 2014 Aug;14(8):742-50
25022435
Expert Rev Anti Infect Ther. 2015 Apr;13(4):463-71
25645293
Shock. 2005 Dec;24 Suppl 1:52-7
16374373
J Gastrointest Surg. 2008 Mar;12(3):592-600
17846853
PLoS One. 2016 Feb 10;11(2):e0149136
26862765
PLoS One. 2016 Feb 05;11(2):e0148142
26849138
Oncotarget. 2016 Mar 8;7(10):10962-75
26918357
J Immunol. 1992 May 1;148(9):2724-30
1315357
Shock. 2012 Jan;37(1):56-62
21921828
Shock. 2014 Jun;41(6):463-75
24569509
MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31
26247436
Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R1048-53
15947070
Crit Care Med. 2012 Mar;40(3):754-61
21963582
Shock. 1999 Aug;12(2):118-26
10446892
J Immunol. 2012 Nov 1;189(9):4648-56
23008446
Intensive Care Med. 2015 Oct;41(10 ):1739-51
26194026
Crit Care. 2011;15(6):R267
22085732
Shock. 2012 Feb;37(2):164-9
22089192
Crit Care Med. 2013 Feb;41(2):580-637
23353941
Shock. 2008 Aug;30(2):127-34
18197142